Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3218394
Max Phase: Preclinical
Molecular Formula: C39H63N13O16
Molecular Weight: 970.01
Molecule Type: Small molecule
Associated Items:
ID: ALA3218394
Max Phase: Preclinical
Molecular Formula: C39H63N13O16
Molecular Weight: 970.01
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](OC(=O)NCCCCCCCn2cc(CCCCNC(=O)O[C@@H]([C@@H]3OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]3NC(C)=O)[C@H](O)CO)nn2)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N
Standard InChI: InChI=1S/C39H63N13O16/c1-19(55)46-28-22(48-36(40)41)14-26(34(59)60)65-32(28)30(24(57)17-53)67-38(63)44-11-7-4-3-5-9-13-52-16-21(50-51-52)10-6-8-12-45-39(64)68-31(25(58)18-54)33-29(47-20(2)56)23(49-37(42)43)15-27(66-33)35(61)62/h14-16,22-25,28-33,53-54,57-58H,3-13,17-18H2,1-2H3,(H,44,63)(H,45,64)(H,46,55)(H,47,56)(H,59,60)(H,61,62)(H4,40,41,48)(H4,42,43,49)/t22-,23-,24+,25+,28+,29+,30+,31+,32+,33+/m0/s1
Standard InChI Key: ZRRIEOQUEJVUFM-BVXSRWBHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 970.01 | Molecular Weight (Monoisotopic): 969.4516 | AlogP: -4.11 | #Rotatable Bonds: 27 |
Polar Surface Area: 463.35 | Molecular Species: ZWITTERION | HBA: 19 | HBD: 16 |
#RO5 Violations: 3 | HBA (Lipinski): 29 | HBD (Lipinski): 18 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.08 | CX Basic pKa: 11.82 | CX LogP: -8.32 | CX LogD: -8.32 |
Aromatic Rings: 1 | Heavy Atoms: 68 | QED Weighted: 0.02 | Np Likeness Score: 0.01 |
1. Fraser BH, Hamilton S, Krause-Heuer AM, Wright PJ, Greguric I, Tucker SP, Draffan AG, Fokin VV, Sharpless KB. (2013) Synthesis of 1,4-triazole linked zanamivir dimers as highly potent inhibitors of influenza A and B, 4 (2): [10.1039/C2MD20300F] |
Source(1):